Novo Nordisk remains a strong buy despite share price dip, thanks to its robust drug pipeline, massive market potential, and ...

When a “boring” healthcare stock posts a 7% surge intraday, investors take notice. That's exactly what happened when CVS Health delivered its second-quarter 2025 earnings on July 31. The healthcare ...